Thomas Milz

Corporate Officer/Principal presso APONTIS PHARMA AG

60 anni

Health Technology

Consumer Services

Finance

Profilo

Thomas Milz is currently the Co-Managing Director at PP Apontis Pharma GmbH and the Chief Product Officer at APONTIS PHARMA AG.
Previously, he held positions such as Director-Strategic Projects & Market Access at UCB Pharma GmbH from 2007 to 2016, Director-Strategic Business Development at APONTIS PHARMA.
Deutschland GmbH & Co. KG from 2017 to 2018 and from 2019 to 2021, Marketing Manager at Schwarz Pharma Deutschland GmbH from 1999 to 2007, Marketing Manager at Sanol GmbH from 1999 to 2007, and Manager-Product Regulations at Madaus AG from 1996 to 1997.
He also worked as a Manager-Prostavasin Product at UCB Pharma GmbH from 1993 to 1996.
Mr. Milz obtained his undergraduate degree from Fachhochschule Düsseldorf in 1991.

Posizioni attive di Thomas Milz

Società	Posizione	Inizio
APONTIS PHARMA AG	Corporate Officer/Principal	01/01/2021
PP Apontis Pharma GmbH PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019.	Amministratore Delegato	01/05/2021

Tutte le posizioni attive di Thomas Milz

Precedenti posizioni note di Thomas Milz

Società	Posizione	Fine
Apontis Pharma GmbH & Co. KG Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany.	Corporate Officer/Principal	01/01/2018
UCB Pharma GmbH UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.	Corporate Officer/Principal	01/01/2016
Schwarz Pharma Deutschland GmbH	Corporate Officer/Principal	01/01/1999
Sanol GmbH	Vendite & Marketing	01/01/2007
Madaus AG	Corporate Officer/Principal	01/01/1997

Vedi nel dettaglio l'esperienza di Thomas Milz

Formazione di Thomas Milz

Fachhochschule Düsseldorf

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas Milz

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
APONTIS PHARMA AG	Health Technology

Aziende private	6
UCB Pharma GmbH UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.	Health Technology
Schwarz Pharma Deutschland GmbH
Apontis Pharma GmbH & Co. KG Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany.	Health Technology
PP Apontis Pharma GmbH PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019.	Finance
Sanol GmbH
Madaus AG

Vedi le connessioni aziendali